Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Oral Chaperone Therapy Migalastat for the Treatment of Fabry Disease: Potentials and Pitfalls of Real-World Data

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 基于发病机制治疗遗传性神经发育障碍的未来之路

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Management of first responder programmes for out-of-hospital cardiac arrest during the COVID-19 pandemic in Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Switching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation: Differences According to Dose

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Vitamin K antagonists vs. direct oral anticoagulants after transcatheter aortic valve implantation in atrial fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pulmonary Arterial Enlargement in Well-Treated Persons With Human Immunodeficiency Virus

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Use of some nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with increased cardiovascular risk in several patient groups, but whether this excess risk exists in apparently healthy individuals has not been clarified. Using a historical cohort design, we estimated the risk of death and myocardial infarction associated with the use of NSAIDs. Participants in the study were selected from the Danish population and were defined as healthy according to a history of no hospital admissions and no concomitant selected pharmacotherapy. The source population consisted of 4,614,807 individuals, of whom 1,028,437 were included in the study after applying selection criteria. Compared to no NSAID use, hazard ratios (95% confidence limits) for death/myocardial infarction were 1.01 (0.96-1.07) for ibuprofen, 1.63 (1.52-1.76) for diclofenac, 0.97 (0.83-1.12) for naproxen, 2.13 (1.89-2.41) for rofecoxib, and 2.01 (1.78-2.27) for celecoxib. A dose-dependent increase in cardiovascular risk was seen for selective COX-2 inhibitors and diclofenac. Caution should be exercised in NSAID use in all individuals, and particularly high doses should be avoided if possible.
Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume85
Issue number2
Pages (from-to)190-7
Number of pages7
ISSN0009-9236
DOIs
Publication statusPublished - 2008

Bibliographical note

Keywords: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Cohort Studies; Cross-Over Studies; Death; Denmark; Female; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Young Adult

ID: 172529